8^th World Congress on Cardiology November 06-30, -0001 Las Vegas, USA

Yoshiaki Omura received Oncological Residency training at Cancer Institute of Columbia University & Doctor of Science Degree through research on Pharmaco-Electro-Physiology of Single Cardiac Cells in-vivo and in-vitro from Columbia University. He researched EMF Resonance phenomenon between 2 identical molecules for non-invasive detection of molecules, at Graduate Experimental Physics Dept., Columbia University for which he received U.S. patent, and that became the main part of Bi-Digital O-Ring Test that he developed. He published over 270 original research articles, many chapters, & 9 books. He is currently Adjunct Prof. of Family & Community Medicine, New York Medical College; President & Prof. of Int’l College of Acupuncture & Electro-Therapeutics, NY; Editor in Chief, Acupuncture & Electro-Therapeutics Research, Int’l Journal of Integrative Medicine, (indexed by 17 major int’l Indexing Periodicals); Formerly, he was also Adjunct Prof. or Visiting Prof. in Universities in USA, France, Italy, Ukraine, Japan, Korea, & China.

EMF Resonance phenomenon between 2 identical molecules for non-invasive detection of molecules, at Graduate Experimental Physics Dept.

Dr. Leigh J. Mack is currently the Director of Clinical Research for Emergency MCG (multifunction cardiogram using AI and large data for advanced diagnostics). He is also a graduate of USAT Montserrat; holding both a MD and PhD degrees. Dr. Mack has post graduate training in Nanotechnology (nanomedicine) fro University of Oxford. He trained at John Radcliffe Hospital (University of Oxford/NHS) in Trauma Plastics. Dr. Mack is a Certified Principal Investigator (CPI - ACRP); and a Fellow of the Academy of Physicians in Clinical Research. Recently, he assisted as a member of the ACRP Academy Standards Setting Committee for the new CPI exam. Dr. Mack served in the US Army National Guard for 7 years.

MCG Diagnostics of CAD/MACE,Pressure Ulcer (Stage 3) Healing Times, Alzheimer’s Class IV Laser Treatment.

Prof. Yehuda Adler is Director of Development of Medical Resource, Director of Internship Committee, Director of the Talpiot Medical Leadership Program (a revolutionary program to build medical leadership in Israel), and Director of health professions at the Chaim Sheba Medical Centre, Israel. He is a member of the National Council for Prevention and Treatment of Cardiovascular Diseases at the Ministry of Health in Israel. He is also a Vice Chair of the Nucleus, The ESC's Committee for Myocardial and Pericardial diseases. Prof. Adler wrote the ESC guidelines for pericardial disease in 2005 and chaired the ESC guidelines for pericardial disease in 2015.

Myocardial and Pericardial diseases.

Dr. Holmes special areas of interest include acute coronary syndromes, interventional cardiology, restenosis, vascular biology, and risk outcomes analysis. In addition, he has been involved in the development of new catheter designs for stroke prevention using left atrial appendage occlusion technology. He has been involved with the introduction and dispersion of transcatheter aortic valve replacement in the United States working with both ACC and the Society for Thoracic Surgery (STS). As part of that, he has been involved with regulatory agencies including FDA and CMS. This collaboration has led to the development of a working group on Early Feasibility Studies (EFS). Finally, he is involved in the development of continued application of percutaneous coronary intervention technology to noncoronary vascular beds.

Acute coronary syndromes, Interventional cardiology, restenosis, Vascular biology, and Risk outcomes analysis

Dr. Monika Leja is a clinical assistant professor and specialist in cardio-oncology at the University of Michigan Frankel Cardiovascular Center, Ann Arbor. She has developed a cardio-oncology clinic focusing on the cardiac health of cancer patients from chemotherapy to survivorship. Her clinic includes patients with cardiotoxicity from their chemotherapy, cardiac tumors, cardiac amyloid related to myelodysplastic disease, carcinoid heart disease, radiation induced cardiac disease, hypertension induced by chemotherapy, and all cardiac complications from cancer therapy. She has started a unique cardiac tumor program, first of its kind in Michigan. This field is pushing the frontier of health care for patients who perhaps have a preexisting heart condition and are diagnosed with cancer, or patients who are suffering from the toxic side effects of cancer treatment drugs.

Chemotherapy, cardiac tumors, cardiac amyloid related to myelodysplastic disease, carcinoid heart disease, radiation induced cardiac disease, hypertension induced by chemotherapy, and all cardiac complications from cancer therapy.

Dr Subodh Verma is a cardiac surgeon‐scientist at St Michael’s Hospital, Professor at the University of Toronto and the Canada Research Chair in Atherosclerosis. He has received the Howard Morgan Award for Distinguished Achievements in Cardiovascular Research and the Royal College of Physicians and Surgeons of Canada Gold Medal in Surgery. He is a member of the American Association of Thoracic Surgeons and the College of New Scholars, Artists and Scientists, Royal Society of Canada. Dr Verma has an h‐index of 61, with 14,482 total citations to 281 publications. Dr Verma spearheads the CardioLink clinical trials platform at St. Michael's Hospital and oversees a pre‐clinical research team that focuses on identifying novel biomarkers in cardiovascular health and developing innovative cardiovascular remedies.

Atherosclerosis,Thoracic Surgeons, Cardiovascular Health, Developing Innovative Cardiovascular Remedies.

Bill Andrews is the President and CEO of Sierra Sciences. As a scientist, athlete and executive, he continually pushes the envelope and challenges convention. He has been featured in Popular Science, The Today Show and numerous documentaries on the topic of life extension. In his 32 year biotech career, he has focused the last 20 years on finding ways to extend the human lifespan and healthspan through telomere maintenance. As one of the principal discoverers of both the RNA and protein components of human telomerase, Dr. Andrews was awarded 2 nd place as “National Inventor of the Year” in 1997. He earned his Ph.D. in Molecular and Population Genetics at the University of Georgia in 1981. He has served as Senior Scientist at Armos Corporation and Codon Corporation, Director of Molecular Biology at Berlex Biosciences and at Geron Corporation, and Director of Technology Development at EOS Biosciences. He is also a named inventor on 45 US issued patents on telomerase and author of numerous scientific research studies published in peer reviewed scientific journals. Bill is also an avid ultramarathon runner. At the age of 61, he regularly competes in 100k and 100+ mile runs often finishing at the top of his age group. These grueling races have taken him all over the world to race in some of the most extreme environments, from Death Valley to the Himalayas.

RNA, human telomerase, Population Genetics, Molecular Biology

Dr. Azimi is a proven respected and experienced cardiovascular and endovascular physician who treats the whole patient and not solely an organ system. Treating patients as family and focusing on prevention has allowed for superior care and results in his practice. He has gained local, national and international recognition. After studying chemistry at Columbia University in New York City, he finished Dartmouth Medical School, followed by the prestigious University of Colorado Health Sciences Center residency program in internal medicine, then followed by Yale University where he trained in cardiology, nuclear cardiology and cardiac and peripheral interventions. He is quadruple board certified and re certified (in internal medicine, cardiovascular disease, interventional cardiology and nuclear cardiology). He has gained local and national recognition.He is voted by his peers as one of San Diego Magazines's Top Doctors in interventional cardiology 2013 and 2014 and by the same magazine as voted by his peers in cardiovascular disease in 2016. Castle Connolly has chosen him as Top Doctor in Interventional Cardiology in 2013, 2014, and 2015, and 2016. Additionally, the Consumer's Research Council of America has added him to the list of America's Top Cardiologists in 2013, 2014, 2015 and 2016 and he has been Doctor's of Excellence in Leaders of Healthcare publication 2014, 2015 and 2016 edition. He has been academically involved teaching students from USC and Midwestern School of Medicine. He serves on editorial board of Cardiology and Vascular Journal as well as Vascular Disease Management. where he also has a Blog. He has numerous publications in peer reviewed journals. He has lectured locally and nationally on diverse topics as well as had media appearances discussing important health topics.

Internal Medicine, General Cardiology, Nuclear Cardiology, Preventive Cardiology, Interventional Cardiology

Manuela Stoicescu is Consultant Internal Medicine Physician (PhD in Internal Medicine), Assistant Professor of University of Oradea, Faculty of Medicine and Pharmacy, Medical Disciplines Department, Romania. She was invited as a speaker at more than 30 International Conferences is USA, China, Japan, Canada, Thailand, Dubai, Spain, Germany, is Committing Organizing Member at many International Conferences, is editorial board member in two ISSN prestigious Journal in U.S.A, published more than 20 articles in prestigious ISSN Journals in U.S.A. She published five books: two books for students, two books on Amazon at International Editor–LAP Lambert Publishing Academic House in Germany- “Sudden Cardiac Death in the Young” and “Side Effects of Antiviral Hepatitis Treatment”, one monograph:“High blood pressure in the young a ignored problem!”, two chapter books – Cardiovascular disease: Causes, Risks, Management CVD1- Causes of Cardiovascular Disease 1.5,1.6, U.S.A on Amazon. , a book in USA -‘Tumor Markers in Hypertensive Young Patients”

Tumor Markers, Cardiovascular Disease, Hepatitis, Internal Medicine